BioCentury
ARTICLE | Company News

Amylin management update

June 7, 2010 7:00 AM UTC

Amylin Pharmaceuticals Inc. (NASDAQ:AMLN), San Diego, Calif. Business: Endocrine Promoted: Christian Weyer to SVP of R&D from VP of medical development; he replaces Orville Kolterman, who becomes SVP ...